
The results and the meaning of EMPA-REG OUTCOME and LEADER studies for modern diabetology: in search of ideal combination
Author(s) -
В. В. Салухов
Publication year - 2019
Publication title -
medicinskij sovet
Language(s) - English
Resource type - Journals
eISSN - 2658-5790
pISSN - 2079-701X
DOI - 10.21518/2079-701x-2019-4-44-51
Subject(s) - empagliflozin , medicine , semaglutide , liraglutide , canagliflozin , myocardial infarction , diabetes mellitus , cardiology , type 2 diabetes , intensive care medicine , endocrinology